Trials / Completed
CompletedNCT00540098
Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder
A Randomized, Controlled Trial on the Effects of Paroxetine Versus Placebo in Combination With Aerobic Exercise or Relaxation Training in the Treatment of Panic Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- University of Göttingen · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Efficacy and safety of a 10-weeks treatment protocol of paroxetine vs. placebo in combination with regular aerobic exercise (running) or regular relaxation training in the treatment of panic disorder.
Detailed description
In continuation of prior work from our group (Broocks A, Bandelow B, Pekrun G, et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998; 155(5):603-9.) it is the purpose of this trial to test the assumed superiority of a combined therapy of paroxetine and aerobic exercise compared to placebo or unspecific relaxation training in panic disorder. Participants were randomized to a 10 week treatment protocol of paroxetine 40 mg daily or placebo in combination with regular exercise or regular relaxation after having given informed consent and screening of in- and exclusion criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paroxetine + aerobic exercise | paroxetine, 40 mg once daily + regular aerobic exercise |
| DRUG | Paroxetine + relaxation | paroxetine, 40 mg once daily + regular relaxation training |
| DRUG | Placebo + aerobic exercise | placebo pill once daily + regular aerobic exercise |
| DRUG | Placebo + relaxation | placebo pill once daily + regular relaxation training |
Timeline
- Start date
- 2001-09-01
- Completion
- 2005-06-01
- First posted
- 2007-10-05
- Last updated
- 2007-10-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00540098. Inclusion in this directory is not an endorsement.